Valneva files for chikungunya vaccine authorization with health canada

Saint- herb lain (france ) , may 30 , 2 02 3 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announces the filing of a regulatory application with health canada for marketing approval of the company's single-shot chikungunya vaccine candidate, vla1553, in persons aged 18 years and above. if accepted, health canada will provide additional information on the potential approval timeline.
VALN Ratings Summary
VALN Quant Ranking